Business Description

Translate Bio Inc logo
Translate Bio Inc
NAICS : 325412 SIC : 2833
ISIN : US89374L1044
Description
Translate Bio Inc is a clinical-stage mRNA therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction. The company is developing MRT5005, for the treatment of cystic fibrosis (CF) and MRT5201, for the treatment of ornithine transcarbamylase (OTC) deficiency.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 11.53
Equity-to-Asset 0.46
Debt-to-Equity 0.14
Debt-to-EBITDA 1.12
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 6/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 4.11
Distress
Grey
Safe
Beneish M-Score 3.05
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EPS without NRI Growth Rate 54.8
Future 3-5Y Total Revenue Growth Rate -14.75

Momentum Rank

Name Current Vs Industry Vs History
6-1 Month Momentum % 53.41
12-1 Month Momentum % 168.61

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 8.8
Quick Ratio 8.8
Cash Ratio 8.19

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -20.3

Financials

TBIO's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:TBIO

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Translate Bio Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 225.086
EPS (TTM) ($) 0.506
Beta 0
Volatility % 113.1
14-Day RSI 0
14-Day ATR ($) 0.403571
20-Day SMA ($) 0
12-1 Month Momentum % 168.61
52-Week Range ($) 11.91 - 37.985
Shares Outstanding (Mil) 75.59

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 6
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Translate Bio Inc Filings

Filing Date Document Date Form
No Filing Data

Translate Bio Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Translate Bio Inc Frequently Asked Questions

What is Translate Bio Inc(TBIO)'s stock price today?
The current price of TBIO is $37.36. The 52 week high of TBIO is $37.99 and 52 week low is $11.91.
When is next earnings date of Translate Bio Inc(TBIO)?
The next earnings date of Translate Bio Inc(TBIO) is .
Does Translate Bio Inc(TBIO) pay dividends? If so, how much?
Translate Bio Inc(TBIO) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1